Your browser doesn't support javascript.
loading
Diagnostic Utility of Smartwatch Technology for Atrial Fibrillation Detection - A Systematic Analysis.
Elbey, Mehmet Ali; Young, Daisy; Kanuri, Sri Harsha; Akella, Krishna; Murtaza, Ghulam; Garg, Jalaj; Atkins, Donita; Bommana, Sudha; Sharma, Sharan; Turagam, Mohit; Pillarisetti, Jayashree; Park, Peter; Tummala, Rangarao; Shah, Alap; Koerber, Scott; Shivamurthy, Poojita; Vasamreddy, Chandrasekhar; Gopinathannair, Rakesh; Lakkireddy, Dhanunjaya.
Affiliation
  • Elbey MA; Arrhythmia Research Fellow, Kansas City Heart Rhythm Institute, Overland Park, Kansas.
  • Young D; Department of Internal Medicine, Stony Brook Southampton Hospital, Southampton, NY.
  • Kanuri SH; Arrhythmia Research Fellow, Kansas City Heart Rhythm Institute, Overland Park, Kansas.
  • Akella K; Arrhythmia Research Fellow, Kansas City Heart Rhythm Institute, Overland Park, Kansas.
  • Murtaza G; Arrhythmia Research Fellow, Kansas City Heart Rhythm Institute, Overland Park, Kansas.
  • Garg J; Division of Cardiology, Cardiac Arrhythmia Service, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Atkins D; Division of Cardiac Electrophysiology, Kansas City Heart Rhythm Institute & Research Foundation; Overland Park Regional Medical Center, HCA Midwest Overland Park, Kansas.
  • Bommana S; Division of Cardiac Electrophysiology, Kansas City Heart Rhythm Institute & Research Foundation; Overland Park Regional Medical Center, HCA Midwest Overland Park, Kansas.
  • Sharma S; Division of Cardiac Electrophysiology, Kansas City Heart Rhythm Institute & Research Foundation; Overland Park Regional Medical Center, HCA Midwest Overland Park, Kansas.
  • Turagam M; Helmsley Electrophysiology Center, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Pillarisetti J; University of Texas Health Science Center at San Antonio, San Antonio, TX.
  • Park P; Division of Cardiac Electrophysiology, Kansas City Heart Rhythm Institute & Research Foundation; Overland Park Regional Medical Center, HCA Midwest Overland Park, Kansas.
  • Tummala R; Division of Cardiac Electrophysiology, Kansas City Heart Rhythm Institute & Research Foundation; Overland Park Regional Medical Center, HCA Midwest Overland Park, Kansas.
  • Shah A; Division of Cardiac Electrophysiology, Kansas City Heart Rhythm Institute & Research Foundation; Overland Park Regional Medical Center, HCA Midwest Overland Park, Kansas.
  • Koerber S; Division of Cardiac Electrophysiology, Kansas City Heart Rhythm Institute & Research Foundation; Overland Park Regional Medical Center, HCA Midwest Overland Park, Kansas.
  • Shivamurthy P; Division of Cardiac Electrophysiology, Kansas City Heart Rhythm Institute & Research Foundation; Overland Park Regional Medical Center, HCA Midwest Overland Park, Kansas.
  • Vasamreddy C; Division of Cardiac Electrophysiology, Kansas City Heart Rhythm Institute & Research Foundation; Overland Park Regional Medical Center, HCA Midwest Overland Park, Kansas.
  • Gopinathannair R; Division of Cardiac Electrophysiology, Kansas City Heart Rhythm Institute & Research Foundation; Overland Park Regional Medical Center, HCA Midwest Overland Park, Kansas.
  • Lakkireddy D; Division of Cardiac Electrophysiology, Kansas City Heart Rhythm Institute & Research Foundation; Overland Park Regional Medical Center, HCA Midwest Overland Park, Kansas.
J Atr Fibrillation ; 13(6): 20200446, 2021.
Article de En | MEDLINE | ID: mdl-34950348
ABSTRACT

BACKGROUND:

Smartphone technologies have been recently developed to assess heart rate and rhythm, but their role in accurately detecting atrial fibrillation (AF) remains unknown.

OBJECTIVE:

We sought to perform a meta-analysis using prospective studies comparing Smartwatch technology with current monitoring standards for AF detection (ECG, Holter, Patch Monitor, ILR).

METHODS:

We performed a comprehensive literature search for prospective studies comparing Smartwatch technology simultaneously with current monitoring standards (ECG, Holter, and Patch monitor) for AF detection since inception to November 25th, 2019. The outcome studied was the accuracy of AF detection. Accuracy was determined with concomitant usage of ECG monitoring, Holter monitoring, loop recorder, or patch monitoring.

RESULTS:

A total of 9 observational studies were included comparing smartwatch technology, 3 using single-lead ECG monitoring, and six studies using photoplethysmography with routine AF monitoring strategies. A total of 1559 patients were enrolled (mean age 63.5 years, 39.5% had an AF history). The mean monitoring time was 75.6 days. Smartwatch was non-inferior to composite ECG monitoring strategies (OR 1.06, 95% CI 0.93 - 1.21, p=0.37), composite 12 lead ECG/Holter monitoring (OR 0.90, 95% CI 0.62 - 1.30, p=0.57) and patch monitoring (OR 1.28, 95% CI 0.84 - 1.94, p=0.24) for AF detection. The sensitivity and specificity for AF detection using a smartwatch was 95% and 94%, respectively.

CONCLUSIONS:

Smartwatch based single-lead ECG and photoplethysmography appear to be reasonable alternatives for AF monitoring.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Diagnostic_studies / Observational_studies / Systematic_reviews Langue: En Journal: J Atr Fibrillation Année: 2021 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Diagnostic_studies / Observational_studies / Systematic_reviews Langue: En Journal: J Atr Fibrillation Année: 2021 Type de document: Article